EP 3968985 A1 20220323 - COMBINATION THERAPIES WITH BISPECIFIC ANTI-EGFR/C-MET ANTIBODIES AND THIRD GENERATION EGFR TYROSINE KINASE INHIBITORS

Title (en)

COMBINATION THERAPIES WITH BISPECIFIC ANTI-EGFR/C-MET ANTIBODIES AND THIRD GENERATION EGFR TYROSINE KINASE INHIBITORS

Title (de)

KOMBINATIONSTHERAPIEN MIT BISPEZIFISCHEN ANTI-EGFR/C-MET-ANTIKÖRPERN UND EGFR-TYROSINKINASE-INHIBITOREN DER DRITTEN GENERATION

Title (fr)

POLYTHÉRAPIES AVEC DES ANTICORPS ANTI-EGFR/C-MET BISPÉCIFIQUES ET DES INHIBITEURS DE TYROSINE KINASE EGFR DE TROISIÈME GÉNÉRATION

Publication

EP 3968985 A1 20220323 (EN)

Application

EP 20806609 A 20200514

Priority

IB 2020054594 W 20200514
US 201962847605 P 20190514

Abstract (en)

[origin: CA3140360A1] The present invention relates to combination therapies with bispecific anti-EGFR/c-Met antibodies and 3rd generation EGFR tyrosine kinase inhibitors.

IPC 8 full level

A61K 31/4155 (2006.01); A61K 31/395 (2006.01); A61K 31/5355 (2006.01); C07D 413/14 (2006.01); C07K 16/28 (2006.01)

CPC (source: EP IL KR)

A61K 31/506 (2013.01 - EP IL); A61K 31/517 (2013.01 - EP IL); A61K 31/5377 (2013.01 - EP IL KR); A61K 39/39558 (2013.01 - IL KR); A61K 45/06 (2013.01 - EP IL KR); A61P 35/00 (2018.01 - EP IL KR); C07K 16/2863 (2013.01 - IL KR); A61K 39/39558 (2013.01 - EP); A61K 2039/505 (2013.01 - IL); A61K 2300/00 (2013.01 - IL KR); C07K 16/2863 (2013.01 - EP); C07K 2317/31 (2013.01 - EP IL KR); C07K 2317/51 (2013.01 - IL KR); C07K 2317/515 (2013.01 - IL KR); C07K 2317/56 (2013.01 - IL KR); C07K 2317/565 (2013.01 - IL KR); C07K 2317/73 (2013.01 - EP IL KR)

C-Set (source: EP)

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

DOCDB simple family (publication)

AU 2020275272 A1 20211202; BR 112021022828 A2 20220412; CA 3140360 A1 20201119; CN 113840601 A 20211224; EA 202193117 A1 20220211; EP 3968985 A1 20220323; EP 3968985 A4 20230726; IL 287962 A 20220101; JP 2022531980 A 20220712; KR 20220010731 A 20220126; MA 55978 A 20220323; MX 2021013955 A 20220311; SG 11202112412Q A 20211230

DOCDB simple family (application)

AU 2020275272 A 20200514; BR 112021022828 A 20200514; CA 3140360 A 20200514; CN 202080035662 A 20200514; EA 202193117 A 20200514; EP 20806609 A 20200514; IL 28796221 A 20211109; JP 2021567974 A 20200514; KR 20217040739 A 20200514; MA 55978 A 20200514; MX 2021013955 A 20200514; SG 11202112412Q A 20200514